USP-14 inhibitors (Progenra)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameUSP-14 inhibitors (Progenra)
Drug Alias Nameubiquitin specific protease 14 inhibitors (Progenra)P-0086672P-0101559
ClassificationSmall molecules
Mechanisms of ActionUbiquitin specific peptidase 14 inhibitorsCNS modulators
TargetsUbiquitin specific peptidase 14
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProgenra Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProgenra Inc
Active IndicationsN/A
Inactive IndicationsCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A